Depression and cardiovascular disease: mind the gap in the guidelines

Area of Science:

• Cardiology
• Psychiatry
• Public Health

Background:

• Patients with cardiovascular disease (CVD) have higher depression rates than the general population.
• Co-occurring CVD and depression worsen quality of life, outcomes, and increase mortality.
• Depression complicates disease management, medication adherence, and lifestyle changes in CVD patients.

Purpose of the Study:

• To evaluate how cardiovascular disease clinical practice guidelines (CPGs) address depression.
• To assess the inclusion of practical management guidance for depression within CVD CPGs.

Main Methods:

• Systematic literature search of CPGs published between 2013 and 2024.
• Analysis of 65 CPGs covering various cardiovascular and cerebrovascular conditions.
• Evaluation of guideline content regarding depression screening, treatment, and professional involvement.

Main Results:

• 71% of CPGs acknowledged depression as a risk factor, but only 23% offered both screening and treatment recommendations.
• Few CPGs (12%) referred to dedicated depression CPGs; stroke CPGs provided most recommendations (68%).
• Limited guidance on drug-disease interactions (3%) and no treatment recommendations in women-specific CPGs were found.

Conclusions:

• Current CVD CPGs insufficiently address depression, lacking comprehensive screening and treatment guidance.
• Involving mental health specialists in CPG development is crucial for holistic patient care.
• Tailored depression management strategies for diverse patient populations are needed within CVD CPGs.